Toshihisa Tomoda
4PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 17, 2022
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status.Nobuki Furubayashi, Akinori Minato, Takahito Negishi
|May 10, 2022
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab.Nobuki Furubayashi, Akinori Minato, Takahito Negishi
|Nov 03, 2021
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab.Nobuki Furubayashi, Akinori Minato, Takahito Negishi
|Mar 29, 2021
Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy.Nobuki Furubayashi, Takahito Negishi, Naotaka Sakamoto
Pageof 1
